ADVERTISEMENT

Denesh Chitkara

P037 Effect of Ozanimod Treatment and Discontinuation on Absolute Lymphocyte Count in Moderate-to-Severe Ulcerative Colitis: Results from a Phase 3 Trial

BACKGROUND: Ozanimod is an oral sphingosine 1-phosphate (S1P) receptor modulator selectively targeting S1P 1 and S1P ...

Silvio Danese ;

Subrata Ghosh ;

AnnKatrin Petersen ;

Jean-Frederic Colombel ;

Geert D'Haens ;

Denesh Chitkara ;

Cecilia Marta ;

Lorna Charles ;

12/15/2021

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

October 29 ⁠–⁠ November 2

November 1 ⁠–⁠ November 2

November 6 ⁠–⁠ November 8

NEI Congress

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

WoundCon

November 8

Dermatology Week

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

See Full Calendar

Advertisement

Advertisement